The expression of genes involved in the ergosterol biosynthesis pathway in Candida albicans and Candida dubliniensis biofilms exposed to fluconazole

Mycoses

Volumn 52, Issue 2, 2009, Pages 118-128

  Borecká Melkusová, Silvia ^a   Moran, Gary P ^b   Sullivan, Derek J ^b   Kucharíková, Soňa ^a   Chorvát Jr , Dušan ^c   Bujdáková, Helena ^a  

^a Physics and Informatics   (Slovakia)

^b TRINITY COLLEGE DUBLIN   (Ireland)

^c INTERNATIONAL LASER CENTER   (Slovakia)

Author keywords

Biofilm; Candida albicans; Candida dubliniensis; Resistance

Indexed keywords

2,3 BIS(2 METHOXY 4 NITRO 5 SULFOPHENYL) 2H TETRAZOLIUM 5 CARBOXANILIDE; ERGOSTEROL; FLUCONAZOLE; TETRAZOLIUM; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL GENE; BIOFILM; CANDIDA ALBICANS; CANDIDA DUBLINIENSIS; CELL ADHESION; CLINICAL ASSESSMENT; CLINICAL FEATURE; CONFOCAL LASER MICROSCOPY; GENE EXPRESSION; INCUBATION TIME; INDIVIDUALITY; NONHUMAN; NUCLEOTIDE SEQUENCE; PLANKTON; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPECIES IDENTIFICATION; STEROL SYNTHESIS; THICKNESS; UPREGULATION;

ANTIFUNGAL AGENTS; BIOFILMS; CANDIDA; CANDIDA ALBICANS; DRUG RESISTANCE, FUNGAL; ERGOSTEROL; FLUCONAZOLE; FUNGAL PROTEINS; GENE EXPRESSION REGULATION, FUNGAL; HUMANS; MICROBIAL SENSITIVITY TESTS;

CANDIDA; CANDIDA ALBICANS; CANDIDA DUBLINIENSIS;

EID: 59149083834     PISSN: 09337407     EISSN: 14390507     Source Type: Journal    
DOI: 10.1111/j.1439-0507.2008.01550.x     Document Type: Article

References (57)

1. Douglas LJ. Candida biofilms and their role in infection. Trends Microbiol 2003 11 : 30 36.
2. Ramage G, Martínez M, López-Ribot JL. Candida biofilms on implanted biomaterials: a clinically significant problem. FEMS Yeast Res 2006 6 : 979 86.
3. Tumbarello M, Posteraro B, Trecarichi EM et al. Biofilm production by Candida species and inadequate antifungal therapy as predictors of mortality for patients with candidemia. J Clin Microbiol 2007 45 : 1843 50.
4. Chandra J, Mukherjee PK, Leidich SD et al. Antifungal resistance of candidal biofilms formed on denture acrylic in vitro. J Dent Res 2001 80 : 903 8.
5. Baillie GS, Douglas LJ. Candida biofilms and their susceptibility to antifungal agents. Meth Enzymol 1999 310 : 644 56.
6. Ramage G, VandeWalle K, Wickes BL, López-Ribot JL. Characteristics of biofilm formation by Candida albicans. Rev Iberoam Micol 2001 18 : 163 70.
7. Ramage G, Saville SP, Thomas DP, López-Ribot JL. Candida biofilms: an update. Eukaryot Cell 2005 4 : 633 8.
8. Sullivan D, Coleman D. Candida dubliniensis: an emerging opportunistic pathogen. Curr Top Med Mycol 1997 8 : 15 25.
9. Ramage G, Vande Walle K, Wickes BL, López-Ribot JL. Biofilm formation by Candida dubliniensis. J Clin Microbiol 2001 39 : 3234 40.
10. Chandra J, Kuhn DM, Mukherjee PK, Hoyer LL, McCormick T, Ghannoum MA. Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance. J Bacteriol 2001 183 : 5385 94.
11. Granger BL, Flenniken ML, Davis DA, Mitchell AP, Cutler JE. Yeast wall protein 1 of Candida albicans. Microbiology 2005 151 : 1631 44.
12. Blankenship JR, Mitchell AP. How to build a biofilm: a fungal perspective. Curr Opin Microbiol 2006 9 : 588 94.
13. Morris DP. Bacterial biofilm in upper respiratory tract infections. Curr Infect Dis Rep 2007 9 : 186 92.
14. Gilbert P, Das J, Foley I. Biofilm susceptibility to antimicrobials. Adv Dent Res 1997 11 : 160 7.
15. Hawser SP, Douglas LJ. Resistance of Candida albicans biofilms to antifungal agents in vitro. Antimicrob Agents Chemother 1995 39 : 2128 31.
16. Lewis RE, Kontoyiannis DP, Darouiche RO, Raad II, Prince RA. Antifungal activity of amphotericin B, fluconazole, and voriconazole in an in vitro model of Candida catheter-related bloodstream infection. Antimicrob Agents Chemother 2002 46 : 3499 505.
17. Lamfon H, Porter SR, McCullough M, Pratten J. Susceptibility of Candida albicans biofilms grown in a constant depth film fermentor to chlorhexidine, fluconazole and miconazole: a longitudinal study. J Antimicrob Chemother 2004 53 : 383 5.
18. Ramage G, Vande Walle K, Wickes BL, López-Ribot JL. Standardized method for in vitro antifungal susceptibility testing of Candida albicans biofilms. Antimicrob Agents Chemother 2001 45 : 2475 9.
19. Ramage G, VandeWalle K, Bachmann SP, Wickes BL, López-Ribot JL. In vitro pharmacodynamic properties of three antifungal agents against preformed Candida albicans biofilms determined by time-kill studies. Antimicrob Agents Chemother 2002 46 : 3634 6.
20. Baillie GS, Douglas LJ. Matrix polymers of Candida biofilms and their possible role in biofilm resistance to antifungal agents. J Antimicrob Chemother 2000 46 : 397 403.
21. Kumamoto CA. A contact-activated kinase signals Candida albicans invasive growth and biofilm development. Proc Natl Acad Sci USA 2005 102 : 5576 81.
22. Mateus C, Crow SA Jr., Ahearn DG. Adherence of Candida albicans to silicone induces immediate enhanced tolerance to fluconazole. Antimicrob Agents Chemother 2004 48 : 3358 66.
23. Mukherjee PK, Chandra J, Kuhn DM, Ghannoum MA. Mechanism of fluconazole resistance in Candida albicans biofilms: phase-specific role of efflux pumps and membrane sterols. Infect Immun 2003 71 : 4333 40.
24. García-Sánchez S, Aubert S, Iraqui I, Janbon G, Ghigo JM, d'Enfert C. Candida albicans biofilms: a developmental state associated with specific and stable gene expression patterns. Eukaryot Cell 2004 3 : 536 45.
25. Morschhäuser J. The genetic basis of fluconazole resistance development in Candida albicans. Biochim Biophys Acta 2002 1587 : 240 8.
26. Khot PD, Suci PA, Miller RL, Nelson RD, Tyler BJ. A small subpopulation of blastospores in Candida albicans biofilms exhibit resistance to amphotericin B associated with differential regulation of ergosterol and beta-1,6-glucan pathway genes. Antimicrob Agents Chemother 2006 50 : 3708 16.
27. Henry KW, Nickels JT, Edlind TD. Upregulation of ERG genes in Candida species by azoles and other sterol biosynthesis inhibitors. Antimicrob Agents Chemother 2000 44 : 2693 700.
28. Kelly SL, Lamb DC, Kelly DE et al. Resistance to fluconazole and cross-resistance to amphotericin B in Candida albicans from AIDS patients caused by defective sterol delta5,6-desaturation. FEBS Lett 1997 400 : 80 82.
29. Bloch KE. Sterol structure and membrane function. CRC Crit Rev Biochem 1983 14 : 47 92.
30. Ramage G, Bachmann S, Patterson TF, Wickes BL, López-Ribot JL. Investigation of multidrug efflux pumps in relation to fluconazole resistance in Candida albicans biofilms. J Antimicrob Chemother 2002 49 : 973 80.
31. Yeater KM, Chandra J, Cheng G et al. Temporal analysis of C. albicans gene expression during biofilm development. Microbiology 2007 153 : 2373 85.
32. Melkusová S, Bujdáková H, Volleková A, Myoken Y, Mikami Y. The efficiency of the benzothiazole APB, the echinocandin micafungin, and amphotericin B in fluconazole-resistant Candida albicans and Candida dubliniensis. Pharmazie 2004 59 : 573 4.
33. Fonzi WA, Irwin MY. Isogenic strain construction and gene mapping in Candida albicans. Genetics 1993 134 : 717 28.
34. National Committee for Clinical Laboratory Standards. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts-Second Edition: Approved Standard M27-A2. Wayne, Pa, USA : NCCLS, 2002.
35. Li X, Yan Z, Xu J. Quantitative variation of biofilms among strains in natural populations of Candida albicans. Microbiology 2003 149 : 353 62.
36. Moran GP, Pinjon E, Coleman DC, Sullivan DJ. Analysis of drug resistance in pathogenic fungi. In : Kavanagh K (ed. Medical Mycology. UK : Wiley, Bognor Regis, 2006 : 108 10.
37. Xu J, Ramos AR, Vilgalys R, Mitchell TG. Clonal and spontaneous origins of fluconazole resistance in Candida albicans. J Clin Microbiol 2000 38 : 1214 20.
38. Pinjon E, Moran GP, Jackson CJ et al. Molecular mechanisms of itraconazole resistance in Candida dubliniensis. Antimicrob Agents Chemother 2003 47 : 2424 37.
39. Stokes C, Moran GP, Spiering MJ, Cole GT, Coleman DC, Sullivan DJ. Lower filamentation rates of Candida dubliniensis contribute to its lower virulence in comparison with Candida albicans. Fungal Genet Biol 2007 44 : 920 31.
40. Maneu V, Cervera AM, Martínez JP, Gozalbo D. Molecular cloning and characterization of a Candida albicans gene (EFB1) coding for the elongation factor EF-1 beta. FEMS Microbiol Lett 1996 145 : 157 62.
41. Moran GP, Maccallum DM, Spiering MJ, Coleman DC, Sullivan DJ. Differential regulation of the transcriptional repressor NRG1 accounts for altered host-cell interactions in Candida albicans and Candida dubliniensis. Mol Microbiol 2007 66 : 915 29.
42. Green CB, Zhao X, Yeater KM, Hoyer LL. Construction and real-time RT-PCR validation of Candida albicans PALS-GFP reporter strains and their use in flow cytometry analysis of ALS gene expression in budding and filamenting cells. Microbiology 2005 151 : 1051 60.
43. Hawser S. Comparisons of the susceptibilities of planktonic and adherent Candida albicans to antifungal agents: a modified XTT tetrazolium assay using synchronised C. albicans cells. J Med Vet Mycol 1996 34 : 149 52.
44. Donlan RM, Costerton JW. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev 2002 15 : 167 93.
45. Mah TF, O'Toole GA. Mechanisms of biofilm resistance to antimicrobial agents. Trends Microbiol 2001 9 : 34 39.
46. Stewart PS. Mechanisms of antibiotic resistance in bacterial biofilms. Int J Med Microbiol 2002 292 : 107 13.
47. Nobile CJ, Nett JE, Andes DR, Mitchell AP. Function of Candida albicans adhesin Hwp1 in biofilm formation. Eukaryot. Cell 2006 5 : 1604 10.
48. Bruzual I, Riggle P, Hadley S, Kumamoto CA. Biofilm formation by fluconazole-resistant Candida albicans strains is inhibited by fluconazole. J Antimicrob Chemother 2007 59 : 441 50.
49. Andes D, Nett J, Oschel P, Albrecht R, Marchillo K, Pitula A. Development and characterization of an in vivo central venous catheter Candida albicans biofilm model. Infect Immun 2004 72 : 6023 31.
50. Wirsching S, Moran GP, Sullivan DJ, Coleman DC, Morschhäuser J. MDR1-mediated drug resistance in Candida dubliniensis. Antimicrob Agents Chemother 2001 45 : 3416 21.
51. Sullivan DJ, Moran GP, Pinjon E et al. Comparison of the epidemiology, drug resistance mechanisms, and virulence of Candida dubliniensis and Candida albicans. FEMS Yeast Res 2004 4 : 369 76.
52. Perea S, López-Ribot JL, Wickes BL et al. Molecular mechanisms of fluconazole resistance in Candida dubliniensis isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis. Antimicrob Agents Chemother 2002 46 : 1695 703.
53. Löffler J, Einsele H, Hebart H, Schumacher U, Hrastnik C, Daum G. Phospholipid and sterol analysis of plasma membranes of azole-resistant Candida albicans strains. FEMS Microbiol Lett 2000 185 : 59 63.
54. Barker KS, Crisp S, Wiederhold N et al. Genome-wide expression profiling reveals genes associated with amphotericin B and fluconazole resistance in experimentally induced antifungal resistant isolates of Candida albicans. J Antimicrob Chemother 2004 54 : 376 85.
55. Geber A, Hitchcock CA, Swartz JE et al. Deletion of the Candida glabrata ERG3 and ERG11 genes: effect on cell viability, cell growth, sterol composition, and antifungal susceptibility. Antimicrob Agents Chemother 1995 39 : 2708 17.
56. White TC, Silver PM. Regulation of sterol metabolism in Candida albicans by the UPC2 gene. Biochem Soc Trans 2005 33 : 1215 8.
57. Shobayashi M, Mitsueda S, Ago M, Fujii T, Iwashita K, Iefuji H. Effects of culture conditions on ergosterol biosynthesis by Saccharomyces cerevisiae. Biosci Biotechnol Biochem 2005 69 : 2381 8.